Driven by financial stocks and pharmaceutical biotechnology stocks, the recent upward trend in Hong Kong stocks, mainly adjustments, is even more obvious. The Hang Seng AH Premium Index fell 1.85% to 143.47 points. This means that A shares as a whole still have a 43.47% premium over H shares. Industry experts and brokerage firms believe that the current AH premium shows that Hong Kong stocks have a clear cost performance advantage. Hong Kong stocks are still attractive in terms of valuation, and the outlook is optimistic. Chen Jianbin, head of investment at the Investment Management Service Office of Dah Sing Bank of Hong Kong, believes that large treasury bond funds may continue to increase their holdings of Hong Kong stocks to provide possible support for the market. Furthermore, the details of the fiscal measures and the scale of the plan may be announced one after another, which may also ignite optimism in the market.

Driven by financial stocks and pharmaceutical biotechnology stocks, the recent upward trend in Hong Kong stocks, mainly adjustments, is even more obvious. The Hang Seng AH Premium Index fell 1.85% to 143.47 points. This means that A shares as a whole still have a 43.47% premium over H shares. Industry experts and brokerage firms believe that the current AH premium shows that Hong Kong stocks have a clear cost performance advantage. Hong Kong stocks are still attractive in terms of valuation, and the outlook is optimistic. Chen Jianbin, head of investment at the Investment Management Service Office of Dah Sing Bank of Hong Kong, believes that large treasury bond funds may continue to increase their holdings of Hong Kong stocks to provide possible support for the market. Furthermore, the details of the fiscal measures and the scale of the plan may be announced one after another, which may also ignite optimism in the market.